Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Ginseng45 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A00223 | 35178098 | Evid Based Complement Alternat Med | A Network Pharmacology Study on the Active Components and Targets of the Radix Ginseng and Radix Bupleuri Herb Pair for Treating Nonalcoholic Fatty Liver Disease. | 2022 | Details |
A00850 | 34948230 | Int J Mol Sci | It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? | 2021 | Details |
A03087 | 34136174 | Food Sci Nutr | Synergistic effects of black ginseng and aged garlic extracts for the amelioration of nonalcoholic fatty liver disease (NAFLD) in mice. | 2021 | Details |
A03377 | 34025131 | J Ginseng Res | Effect of Korean Red Ginseng on metabolic syndrome. | 2020 | Details |
A03796 | 33861449 | Adv Exp Med Biol | Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease. | 2021 | Details |
A03862 | 33841012 | J Ginseng Res | Effect of Korea red ginseng on nonalcoholic fatty liver disease: an association of gut microbiota with liver function. | 2020 | Details |
A03903 | 33824675 | Evid Based Complement Alternat Med | Jian-Gan-Xiao-Zhi Decoction Alleviates Inflammatory Response in Nonalcoholic Fatty Liver Disease Model Rats through Modulating Gut Microbiota. | 2021 | Details |
A03959 | 33807927 | Nutrients | Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation. | 2021 | Details |
A04278 | 33679403 | Front Pharmacol | Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis. | 2021 | Details |
A04345 | 33656663 | Hepatol Int | Gut-liver axis modulation of Panax notoginseng saponins in nonalcoholic fatty liver disease. | 2021 | Details |
A05000 | 33419084 | Antioxidants (Basel) | Antioxidant and Anti-Inflammatory Effects of Korean Black Ginseng Extract through ER Stress Pathway. | 2021 | Details |
A05079 | 33385408 | Life Sci | Transcriptome analysis reveals the efficacy of ginsenoside-Rg1 in the treatment of nonalcoholic fatty liver disease. | 2020 | Details |
A07454 | 32489856 | Integr Med Res | Herbal formulation MIT ameliorates high-fat diet-induced non-alcoholic fatty liver disease. | 2020 | Details |
A07578 | 32437790 | Life Sci | Ginsenoside Rg1 protects against d-galactose induced fatty liver disease in a mouse model via FOXO1 transcriptional factor. | 2020 | Details |
A07699 | 32387461 | J Ethnopharmacol | Ginsenoside Mc1 improves liver steatosis and insulin resistance by attenuating ER stress. | 2020 | Details |
A08299 | 32161549 | Front Pharmacol | Relationship Between Ginsenoside Rg3 and Metabolic Syndrome. | 2020 | Details |
A08338 | 32148418 | J Ginseng Res | Ameliorative effects of black ginseng on nonalcoholic fatty liver disease in free fatty acid-induced HepG2 cells and high-fat/high-fructose diet-fed mice. | 2019 | Details |
A08339 | 32148405 | J Ginseng Res | Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice. | 2018 | Details |
A09072 | 31884405 | Phytomedicine | Protective effect of Hedansanqi Tiaozhi Tang against non-alcoholic fatty liver disease in vitro and in vivo through activating Nrf2/HO-1 antioxidant signaling pathway. | 2019 | Details |
A09253 | 31817227 | Nutrients | Fermented Korean Red Ginseng Extract Enriched in Rd and Rg3 Protects against Non-Alcoholic Fatty Liver Disease through Regulation of mTORC1. | 2019 | Details |
A09965 | 31543103 | Am J Med Sci | Beware Energy Drinks: A Case of a Toxic Triad Syndrome in a Diabetic Patient With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
A11531 | 30854954 | Curr Pharm Biotechnol | Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease. | 2019 | Details |
A12656 | 30344430 | J Ginseng Res | Ginseng seed oil ameliorates hepatic lipid accumulation in vitro and in vivo. | 2017 | Details |
A12762 | 30298748 | Am J Chin Med | Beneficial Effects of Korean Red Ginseng in the Progression of Non-Alcoholic Steatohepatitis via FABP4 Modulation. | 2018 | Details |
A13850 | 29728017 | Zhongguo Zhong Yao Za Zhi | [Ginseng prescription rules and molecular mechanism in treating coronary heart disease based on data mining and integrative pharmacology]. | 2018 | Details |
A15734 | 28737815 | Food Funct | Isofraxidin, a coumarin component improves high-fat diet induced hepatic lipid homeostasis disorder and macrophage inflammation in mice. | 2017 | Details |
A16155 | 28534819 | Int J Mol Sci | Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK. | 2017 | Details |
A16897 | 28106137 | Sci Rep | Ameliorative effects of Compound K and ginsenoside Rh1 on non-alcoholic fatty liver disease in rats. | 2017 | Details |
A17705 | 27642594 | Biomed Res Int | Lipid Regulation Effects of Raw and Processed Notoginseng Radix Et Rhizome on Steatotic Hepatocyte L02 Cell. | 2016 | Details |
A17757 | 27616896 | J Ginseng Res | Anti-inflammatory and antifatigue effect of Korean Red Ginseng in patients with nonalcoholic fatty liver disease. | 2015 | Details |
A19043 | 26806698 | J Pharm Pharmacol | Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice. | 2016 | Details |
A21472 | 25296088 | Arq Gastroenterol | Ginseng, green tea or fibrate: valid options for nonalcoholic steatohepatitis prevention? | 2015 | Details |
A22486 | 24520789 | Zhongguo Zhong Xi Yi Jie He Za Zhi | [Study on the mechanism of action of total saponins of Panax notoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet]. | 2014 | Details |
A23156 | 23998390 | Liver Int | Compound K modulates fatty acid-induced lipid droplet formation and expression of proteins involved in lipid metabolism in hepatocytes. | 2013 | Details |
A23188 | 23975682 | Cochrane Database Syst Rev | Herbal medicines for fatty liver diseases. | 2013 | Details |
A23940 | 23369934 | Food Chem Toxicol | Anti-oxidant and natural killer cell activity of Korean red ginseng (Panax ginseng) and urushiol (Rhus vernicifera Stokes) on non-alcoholic fatty liver disease of rat. | 2013 | Details |
A28755 | 35058729 | J Ginseng Res | Oral administration of Jinan Red Ginseng and licorice extract mixtures ameliorates nonalcoholic steatohepatitis by modulating lipogenesis. | 2021 | Details |
A31251 | 30962734 | J Ginseng Res | Fermented ginseng, GBCK25, ameliorates steatosis and inflammation in nonalcoholic steatohepatitis model. | 2017 | Details |
A44322 | 29021690 | J Ginseng Res | Effect of Korean Red Ginseng in chronic liver disease. | 2017 | Details |
A45411 | 24748831 | J Ginseng Res | AMP-activated protein kinase: An emerging target for ginseng. | 2013 | Details |
A50510 | 35358801 | Biomed Pharmacother | Bioinformatics study of the potential therapeutic effects of ginsenoside Rf in reversing nonalcoholic fatty liver disease. | 2022 | Details |
A50625 | 35322862 | Mol Med Rep | Ginsenoside Rg1 exerts anti‑apoptotic effects on non‑alcoholic fatty liver cells by downregulating the expression of SGPL1. | 2022 | Details |
A52117 | 31012326 | Am J Chin Med | Metabonomics Study on the Hepatoprotective Effect of Panax notoginseng Leaf Saponins Using UPLC/Q-TOF-MS Analysis. | 2019 | Details |
A52185 | 30320914 | J Cell Biochem | Protein translation associated to PERK arm is a new target for regulation of metainflammation: A connection with hepatocyte cholesterol. | 2018 | Details |
A52570 | 25487878 | Sci Rep | Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice. | 2014 | Details |